查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1735661

全球智慧药丸市场规模（按目标区域、应用、最终用户、区域范围）预测至 2025 年

Global Smart Pills Market Size By Target Area (Targeted Drug Delivery, Vital Sign Monitoring), By Application (Large Intestine, Stomach), By End-User (Hospitals, Diagnostic Centers), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

智慧药丸市场规模及预测

2024 年智慧药丸市场规模价值 59.5 亿美元，预计到 2032 年将达到 143.2 亿美元，2026 年至 2032 年的复合年增长率为 12.8%。

  • 智慧药丸是一种可吞服的电子设备，内建感测器、摄影机和药物传输系统，用于监测身体机能并收集即时健康资讯。这些锭剂可用于诊断、监测和定製药物分配，从而改善患者护理。
  • 智慧药丸通常用于诊断胃肠道疾病、追踪服药依从性以及收集患者资料。它们提供了一种非侵入式的替代方案，减少了对标准医疗程序的需求。该技术提高了治疗的精准度，使临床医生能够更好地制定患者护理方案。
  • 未来，智慧医疗可能会利用人工智慧来改善预测性诊断和个人化治疗，其应用有望扩展到包括慢性病管理在内的各个医学学科，从而带来更好的医疗结果和患者满意度。

全球智慧药物市场动态

影响全球智慧药丸市场的关键市场动态是：

关键市场驱动因素

  • 慢性病盛行率不断上升：糖尿病和心血管疾病等慢性病盛行率的上升凸显了对新型健康解决方案的需求。预计到2030年，慢性病将占全球死亡人数的73%，促使医疗保健从业者采用智慧平板电脑来更好地管理疾病并远端患者监护。
  • 感测器技术的进步：微型感测器和连接模组的发展，推动了能够监测各种生理数据的先进智慧锭剂的研发。预计2021-2026年，全球智慧药丸市场的复合年增长率将达到8.3%，主要得益于感测器技术的进步。

主要挑战

  • 资料隐私问题：使用智慧药丸追踪健康数据引发隐私担忧。患者的敏感资讯可能被洩漏、被骇客入侵或被滥用。确保强有力的资料安全措施并遵守 HIPAA 等标准，对于维护患者信任并确保这项技术的广泛应用至关重要。
  • 高成本：智慧平板电脑及相关技术的设计和製造成本高昂，可能会限制其普及。高成本也给医疗保健系统和个人（尤其是在低收入地区）带来了负担，这严重阻碍了该技术的普及和公平使用。
  • 监管障碍：智慧平板电脑的核准流程复杂，需要FDA等监管机构进行全面的安全性和有效性评估。遵循这些法律规范可能既耗时又昂贵。

主要趋势：

  • 人工智慧和机器学习的融合：智慧药丸中人工智慧和机器学习的使用将提高数据处理能力，实现个人化治疗和预测分析，从而获得更好的健康结果。
  • 重视预防性医疗保健：预防性医疗保健变得越来越重要，智慧平板电脑将在监测健康参数和促进主动疾病管理以降低医疗成本方面发挥关键作用。
  • 远端医疗的采用：远端医疗的使用推动了对智慧药丸的需求，透过实现远端监控和患者与医疗保健机构的联繫，增加了医疗保健的可及性和患者参与度。

目录

第一章 智慧药丸全球市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表
  • 市场吸引力

第四章 全球智慧药丸市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章 全球智慧药丸市场（按应用）

  • 概述
  • 胶囊内视镜
  • 靶向药物输送
  • 生命征象监测

第六章 全球智慧药丸市场（按目标区域）

  • 概述
  • 食道
  • 小肠
  • 冒号
  • 胃

第七章 全球智慧药丸市场（按最终用户）

  • 概述
  • 医院
  • 诊断中心

第八章全球智慧药丸市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第九章全球智慧药丸市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略
  • ACE矩阵

第十章 公司简介

  • GE Healthcare
  • Boston Scientific Corporation
  • Given Imaging, Inc.
  • Olympus Corporation
  • BioImages Research Ltd.
  • Medimetrics SA DE CV
  • Karl Storz Gmbh & Co. KG
  • Fujifilm Holdings Corporation
  • Cerner Corporation
  • Proteus Digital Health, Inc.

第十一章 重大进展

  • 产品发布/开发
  • 合併与收购
  • 业务扩展
  • 伙伴关係与合作

第十二章 附录

  • 相关调查
简介目录
Product Code: 32983

Smart Pills Market Size And Forecast

Smart Pills Market size was valued at USD 5.95 Billion in 2024 and is projected to reach USD 14.32 Billion by 2032 growing at a CAGR of 12.8% from 2026 to 2032.

  • Smart pills are ingestible electronic devices that include sensors, cameras, and medicine delivery systems. They monitor internal bodily functions and collect real-time health information. These pills are used for diagnostics, monitoring, and tailored drug distribution, which improves patient care.
  • Smart pills are generally used to diagnose gastrointestinal issues, track drug adherence, and collect patient data. They offer non-invasive alternatives, which reduce the need for standard medical procedures. This technology enhances treatment accuracy and enables clinicians to make better judgments about patient care.
  • In the future, smart medicines will use AI to improve predictive diagnosis and individualized therapy. Their use is predicted to grow in a variety of medical sectors, including chronic disease management, resulting in better healthcare results and patient satisfaction.

Global Smart Pills Market Dynamics

The key market dynamics that are shaping the global smart pills market include:

Key Market Drivers:

  • Increasing Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, such as diabetes and cardiovascular disease, highlights the need for novel health solutions. Chronic diseases are expected to account for 73% of global fatalities by 2030, prompting healthcare practitioners to implement smart tablets for better disease management and remote patient monitoring.
  • Advancements In Sensor Technology: Advancements in miniaturized sensors and connectivity modules have resulted in the development of advanced smart pills capable of monitoring a variety of physiological data. The global smart pill market is expected to develop at an 8.3% CAGR between 2021 and 2026, owing mostly to advancements in sensor technology.

Key Challenges:

  • Data Privacy Concerns: The usage of smart pills to track health data poses privacy issues. Sensitive patient information may be compromised, hacked, or misused. Ensuring strong data security measures and obeying to standards such as HIPAA are critical to sustaining patient trust and widespread use of this technology.
  • High Costs: Smart tablets and their accompanying technologies can be costly to design and manufacture, restricting availability. This high cost can also burden healthcare systems and individuals, especially in low-income areas, creating a significant barrier to universal adoption and fair access to technology.
  • Regulatory Hurdles: The clearance procedure for smart tablets is complex, requiring thorough safety and efficacy assessments by regulatory agencies such as the FDA. Navigating these regulatory frameworks can be time-consuming and potentially costly.

Key Trends:

  • Integration Of AI And Machine Learning: The use of AI and machine learning in smart pills improves data processing capabilities, allowing for tailored treatment and predictive analytics for better health results.
  • Focus On Preventive Healthcare: Preventive healthcare is becoming increasingly important, with smart tablets playing a critical role in monitoring health parameters and promoting proactive illness management to decrease healthcare expenditures.
  • Telemedicine Adoption: Telemedicine usage is boosting demand for smart pills, which allow for remote monitoring and patient-provider contact, thereby enhancing access to care and patient participation.

Global Smart Pills Market Regional Analysis

Here is a more detailed regional analysis of the global smart pills market:

North America:

  • According to Verified Market Research, North America is expected to dominate the global smart pills market.
  • The high frequency of gastrointestinal illnesses in North America promotes the use of smart tablets for diagnosis and therapy. The National Institute of Diabetes and Digestive and Kidney illnesses (NIDDK) estimates that 60 to 70 million Americans suffer from digestive illnesses. This prevalent incidence drives up the need for smart pills as a diagnostic tool.
  • North America's advanced healthcare infrastructure and large healthcare expenditures all contribute to the adoption of smart pills. With U.S. healthcare spending expected to exceed USD 4.1 Trillion by 2020, the region's developed healthcare system promotes the integration of cutting-edge medical technology such as smart pills, hence improving patient care.

Asia Pacific:

  • According to Verified Market Research, Asia Pacific is fastest growing region in global smart pills market.
  • The increasing prevalence of gastrointestinal illnesses in Asia Pacific is pushing the demand for smart pills. Research published in the Journal of Gastroenterology and Hepatology suggests that the prevalence of gastrointestinal problems in the region ranges from 5.5% to 34.2%.
  • In China, approximately 5-6% of the population suffers with irritable bowel syndrome, affecting 70-80 million people. These numbers indicate the increased healthcare needs for digestive health. As traditional techniques of diagnosis and management have limits, smart tablets provide a more advanced, non-invasive approach, making them an appealing choice for improving patient outcomes in gastrointestinal healthcare.

Global Smart Pills Market: Segmentation Analysis

The Global Smart Pills Market is segmented based Target Area, Application, End-User, and Geography.

Smart Pills Market, By Target Area

  • Esophagus
  • Small Intestine
  • Large Intestine
  • Stomach

Based on Target Area, the Global Smart Pills Market is separated into Esophagus, Small Intestine, Large Intestine, and Stomach. In the global smart pill market, the small intestine segment dominates. This is primarily due to its vital function in nutrient absorption and the growing necessity to monitor gastrointestinal illnesses. Smart tablets created for the small intestine allow for accurate detection and treatment of illnesses such as Crohn's disease and celiac disease.

Smart Pills Market, By Application

  • Capsule Endoscopy
  • Targeted Drug Delivery
  • Vital Sign Monitoring

Based on Application, Global Smart Pills Market is divided into Capsule Endoscopy, Targeted Drug Delivery, and Vital Sign Monitoring. Capsule endoscopy is now the most popular use for smart pills worldwide. This approach allows for non-invasive imaging of the gastrointestinal tract, which provides important diagnostic information. The rising prevalence of gastrointestinal illnesses, as well as the demand for effective diagnostic tools, propel it to market leadership, improving patient comfort and procedural efficiency.

Smart Pills Market, By End-User

  • Hospitals
  • Diagnostic Centers

Based on End-User, Global Smart Pills Market is divided into Hospitals and Diagnostic Centers. Hospitals dominate the global smart pill market because of their complete healthcare services, improved technological integration and greater use of remote monitoring systems, which improve patient care and treatment outcomes.

Key Players

  • The Global Smart Pills Market study report will provide valuable insight with an emphasis on the global market. The major players in the market are GE Healthcare, Boston Scientific Corporation, Given Imaging, Inc., Olympus Corporation, BioImages Research Ltd., Medimetrics S.A. DE C.V, Karl Storz Gmbh & Co. KG, Fujifilm Holdings Corporation, Cerner Corporation, Proteus Digital Health, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • Global Smart Pills Market Recent Developments
  • In January 2019, Proteus Digital Health delivered its first digital cancer chemotherapy tablet to aid clinicians in tracking treatment success and adherence among cancer patients.
  • In August 2020, Otsuka paid USD 15 million for Proteus Digital Health, a manufacturer of smart pills.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL SMART PILLS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources
  • 3.5 Market attractiveness

4 GLOBAL SMART PILLS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL SMART PILLS MARKET, BY APPLICATION

  • 5.1 Overview
  • 5.2 Capsule Endoscopy
  • 5.3 Targeted Drug Delivery
  • 5.4 Vital Sign Monitoring

6 GLOBAL SMART PILLS MARKET, BY TARGET AREA

  • 6.1 Overview
  • 6.2 Esophagus
  • 6.3 Small Intestine
  • 6.4 Large Intestine
  • 6.5 Stomach

7 GLOBAL SMART PILLS MARKET, BY END USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers

8 GLOBAL SMART PILLS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL SMART PILLS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies
  • 9.4 ACE Matrix

10 COMPANY PROFILES

  • 10.1 GE Healthcare
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Boston Scientific Corporation
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Given Imaging, Inc.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Olympus Corporation
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 BioImages Research Ltd.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Medimetrics S.A. DE C.V
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Karl Storz Gmbh & Co. KG
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Fujifilm Holdings Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Cerner Corporation
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Proteus Digital Health, Inc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research